An "accidental" laboratory discovery has revealed new potential methods for preventing the flu by uncovering that different flu strains utilize distinct strategies to infect human cells. Researchers at the University of Vermont's Larner College of Medicine, while investigating viral replication, found that the H3N2 influenza A virus specifically relies on a human protein called Rab11B to enter lung cells, a dependency not shared by the H1N1 strain. By targeting and blocking these strain-specific molecules, scientists believe they can halt viral replication and pave the way for novel preventive medications, addressing a critical need for improved influenza treatments beyond current vaccines and antivirals.